This inventor holds 1 USPTO granted patent. Top assignee: Fundacao Oswaldo Cruz-Fiocruz. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Frederico Silva Castelo Branco: Innovator in Tuberculosis Treatment
Introduction
Frederico Silva Castelo Branco is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of medicine, particularly in the treatment of tuberculosis. His innovative work has led to the development of a unique compound that holds promise for improving patient outcomes.
Latest Patents
Frederico holds 1 patent for his invention related to α-ketoacylic isoniazid compounds. This patent details a process for producing these compounds and their use in the treatment of tuberculosis. The compounds are designed to enhance the efficacy of existing treatments, providing a new avenue for combating this serious disease.
Career Highlights
Frederico is affiliated with the Fundação Oswaldo Cruz (Fiocruz), a prominent research institution in Brazil. His work at Fiocruz has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in infectious diseases.
Collaborations
Frederico has worked closely with his coworker, Núbia Boechat, on various projects aimed at advancing medical research and developing new therapeutic strategies. Their collaboration exemplifies the importance of teamwork in scientific innovation.
Conclusion
Frederico Silva Castelo Branco's contributions to tuberculosis treatment through his patented compounds highlight the vital role of inventors in addressing global health challenges. His work continues to inspire future innovations in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile